Tnfrsf1a (TNF receptor superfamily member 1A) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)
Gene: Tnfrsf1a (TNF receptor superfamily member 1A) Rattus norvegicus
Analyze
Symbol: Tnfrsf1a
Name: TNF receptor superfamily member 1A
RGD ID: 621237
Description: Enables protease binding activity; tumor necrosis factor binding activity; and tumor necrosis factor receptor activity. Involved in several processes, including cellular response to estradiol stimulus; regulation of apoptotic process; and regulation of cytokine production. Located in axon; cell surface; and extracellular space. Part of protein-containing complex. Used to study brain ischemia; ischemia; middle cerebral artery infarction; myocardial infarction; and uveitis. Biomarker of several diseases, including root resorption; sciatic neuropathy; transient cerebral ischemia; type 2 diabetes mellitus; and ureteral obstruction. Human ortholog(s) of this gene implicated in several diseases, including IgA glomerulonephritis; TNF receptor–associated periodic syndrome; acne; allergic bronchopulmonary aspergillosis; and rheumatoid arthritis. Orthologous to human TNFRSF1A (TNF receptor superfamily member 1A); PARTICIPATES IN tumor necrosis factor mediated signaling pathway; ceramide signaling pathway; nuclear factor kappa B signaling pathway; INTERACTS WITH (+)-pilocarpine; (S)-nicotine; 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane.
Type: protein-coding
RefSeq Status: PROVISIONAL
Previously known as: MGC105478; p55; p60; TNF-R1; TNF-RI; TNFR-1; TNFR-I; Tnfr1; Tumor necrosis factor receptor; tumor necrosis factor receptor 1; tumor necrosis factor receptor superfamily member 1A; tumor necrosis factor receptor superfamily, member 1a; tumor necrosis factor receptor type I
RGD Orthologs
Human
Mouse
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Black Rat
Alliance Orthologs
More Info more info ...
Is Marker For: Strains:   BN   LEW   DA   ACI/N   F344/NRrrc  
Candidate Gene For: Ciaa4 Cia24
Latest Assembly: GRCr8 - GRCr8 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr84159,837,119 - 159,849,817 (+)NCBIGRCr8GRCr8GRCr8
GRCr8 Ensembl4159,837,032 - 159,849,816 (+)EnsemblGRCr8
mRatBN7.24158,150,815 - 158,163,592 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl4158,150,820 - 158,163,591 (+)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx4164,380,489 - 164,393,199 (+)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.04160,163,415 - 160,176,125 (+)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.04158,802,250 - 158,814,961 (+)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.04157,864,905 - 157,877,634 (+)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl4157,864,969 - 157,877,633 (+)Ensemblrn6Rnor6.0
Rnor_5.04224,881,368 - 224,894,089 (+)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.44162,172,563 - 162,185,252 (+)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera4146,886,949 - 146,899,646 (+)NCBICelera
RGSC_v3.14162,417,498 - 162,430,188 (+)NCBI
RH 3.4 Map41000.9RGD
Cytogenetic Map4q42NCBI
JBrowse:




Disease Annotations     Click to see Annotation Detail View
acne  (ISO)
acquired immunodeficiency syndrome  (ISO)
Acute Experimental Pancreatitis  (IEP)
acute kidney failure  (ISO)
adult respiratory distress syndrome  (ISO)
allergic bronchopulmonary aspergillosis  (ISO)
allergic disease  (ISO)
Alzheimer's disease  (ISO)
amyloidosis  (ISO)
anemia  (ISO)
Anorexia  (ISO)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis  (ISO)
arteriosclerosis  (ISO)
asthma  (ISO)
autoimmune disease  (ISO)
bacterial pneumonia  (ISO)
Behcet's disease  (ISO)
Brain Injuries  (IEP,ISO)
brain ischemia  (IDA,ISO)
Cachexia  (IEP,ISO)
CHARGE syndrome  (ISO)
Chediak-Higashi syndrome  (ISO)
Chronic Hepatitis C  (ISO)
chronic obstructive pulmonary disease  (ISO)
colon carcinoma  (ISO)
colorectal adenoma  (ISO)
congestive heart failure  (ISO)
coronary artery disease  (ISO)
COVID-19  (ISO)
Crohn's disease  (IEP)
cryptogenic organizing pneumonia  (ISO)
cystic fibrosis  (ISO)
cytomegalovirus retinitis  (ISO)
Diabetic Nephropathies  (ISO)
Embryo Loss  (ISO)
End Stage Liver Disease  (IMP)
end stage renal disease  (ISO)
endometrial cancer  (ISO)
Enterovirus Infections  (ISO)
Experimental Arthritis  (IDA,IEP,ISO)
Experimental Autoimmune Uveoretinitis  (ISO)
Experimental Colitis  (IMP)
Experimental Diabetes Mellitus  (IEP,ISO)
Experimental Seizures  (IEP)
extrinsic allergic alveolitis  (ISO)
familial Mediterranean fever  (ISO)
Febrile Seizures  (ISO)
Fever  (ISO)
fibrosarcoma  (ISO)
focal segmental glomerulosclerosis  (ISO)
genetic disease  (ISO)
glomerulonephritis  (ISO)
Human Influenza  (ISO)
Hyperalgesia  (IEP,IMP,ISO)
Hyperoxia  (ISO)
IgA glomerulonephritis  (ISO)
Insulin Resistance  (ISO)
ischemia  (IDA)
kidney disease  (ISO)
Kidney Reperfusion Injury  (ISO)
Legionnaires' disease  (ISO)
Liver Reperfusion Injury  (IEP)
Lung Injury  (ISO)
lung non-small cell carcinoma  (ISO)
lupus nephritis  (ISO)
Metabolic Syndrome  (ISO)
middle cerebral artery infarction  (IMP)
multiple sclerosis  (ISO)
Muscle Weakness  (ISO)
myocardial infarction  (IDA,IEP,IMP)
Nasal Polyps  (ISO)
Nematode Infections  (IEP)
obesity  (ISO)
obstructive sleep apnea  (ISO)
Optic Nerve Injuries  (IEP,ISO)
ovarian cancer  (ISO)
Pain  (IEP)
pneumonia  (ISO)
polymyositis  (ISO)
primary biliary cholangitis  (ISO)
Pseudomonas Infections  (ISO)
psoriasis  (ISO)
Radiation Pneumonitis  (ISO)
renal cell carcinoma  (ISO)
renal fibrosis  (ISO)
Reperfusion Injury  (IEP)
retinal detachment  (ISO)
rheumatoid arthritis  (ISO)
root resorption  (IEP)
sciatic neuropathy  (IEP,ISO)
silicosis  (ISO)
Spinal Cord Compression  (IEP)
Spinal Cord Injuries  (IEP)
squamous cell carcinoma  (ISO)
systemic lupus erythematosus  (ISO)
TNF receptor-associated periodic syndrome  (ISO,ISS)
transient cerebral ischemia  (IEP)
type 2 diabetes mellitus  (IEP,ISO)
ureteral obstruction  (IEP)
uveitis  (IMP,ISO)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-pilocarpine  (EXP)
(-)-citrinin  (ISO)
(-)-epigallocatechin 3-gallate  (ISO)
(1->4)-beta-D-glucan  (ISO)
(S)-colchicine  (ISO)
(S)-nicotine  (EXP,ISO)
1'-acetoxychavicol acetate  (ISO)
1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane  (EXP)
1,2-dichloroethane  (ISO)
1,2-dimethylhydrazine  (ISO)
1,3-dinitrobenzene  (EXP)
1-naphthyl isothiocyanate  (EXP,ISO)
17beta-estradiol  (EXP,ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
2,2'-Methylenebis(4-methyl-6-tert-butylphenol)  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4-dinitrotoluene  (EXP)
2,6-dinitrotoluene  (EXP)
2-amino-2-deoxy-D-glucopyranose  (ISO)
2-methylcholine  (ISO)
2-naphthylamine  (ISO)
3,3'-diindolylmethane  (ISO)
3-chloropropane-1,2-diol  (ISO)
3-isobutyl-1-methyl-7H-xanthine  (ISO)
4,4'-diaminodiphenylmethane  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4-hydroxynon-2-enal  (ISO)
4-tert-butylphenol  (ISO)
5-aza-2'-deoxycytidine  (ISO)
5-fluorouracil  (ISO)
6-Methoxyflavone  (ISO)
6-propyl-2-thiouracil  (EXP)
[des-Arg(9)]-bradykinin  (ISO)
acetamide  (EXP)
acetic acid  (EXP)
acetylsalicylic acid  (ISO)
acrolein  (EXP,ISO)
AH23848  (ISO)
AICA ribonucleotide  (ISO)
aldehydo-D-glucosamine  (ISO)
all-trans-retinoic acid  (ISO)
Aloe emodin  (ISO)
alpha-naphthoflavone  (ISO)
alpha-pinene  (ISO)
aminoguanidine  (ISO)
amphetamine  (EXP)
amphibole asbestos  (ISO)
antirheumatic drug  (ISO)
arachidonic acid  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenite(3-)  (ISO)
arsenous acid  (ISO)
asbestos  (ISO)
asperentin  (ISO)
atorvastatin calcium  (ISO)
azathioprine  (ISO)
Azoxymethane  (ISO)
Bandrowski's base  (ISO)
benzene  (EXP)
benzo[a]pyrene  (ISO)
benzo[a]pyrene diol epoxide I  (ISO)
beta-D-glucosamine  (ISO)
beta-naphthoflavone  (EXP)
Beta-Solamarine  (ISO)
bexarotene  (EXP)
bis(2-chloroethyl) sulfide  (ISO)
bis(2-ethylhexyl) phthalate  (ISO)
bisphenol A  (EXP,ISO)
bisphenol F  (ISO)
bleomycin A2  (ISO)
boric acid  (ISO)
Brevianamide A  (ISO)
butylated hydroxyanisole  (ISO)
Butylparaben  (ISO)
cadmium acetate  (EXP)
cadmium atom  (ISO)
cadmium dichloride  (ISO)
Calphostin C  (ISO)
cannabidiol  (ISO)
capsaicin  (ISO)
capsazepine  (ISO)
carbamazepine  (ISO)
carbon nanotube  (ISO)
carbonyl sulfide  (EXP)
cefaloridine  (EXP)
CGP 52608  (ISO)
chloroform  (EXP)
chloroquine  (ISO)
chlorpyrifos  (ISO)
cholesterol  (EXP)
cisplatin  (ISO)
clobetasol  (ISO)
clofibrate  (EXP)
cobalt dichloride  (ISO)
cocaine  (ISO)
copper atom  (ISO)
copper(0)  (ISO)
copper(II) sulfate  (ISO)
corn oil  (ISO)
crocidolite asbestos  (ISO)
Cuprizon  (EXP)
curcumin  (ISO)
cyclosporin A  (ISO)
DDT  (EXP)
dexamethasone  (EXP,ISO)
dextran sulfate  (ISO)
diarsenic trioxide  (ISO)
diazinon  (ISO)
dibutyl phthalate  (EXP)
dichlorine  (ISO)
diclofenac  (ISO)
dieldrin  (EXP)
diethylstilbestrol  (ISO)
dihydroxyacetone  (ISO)
dimethyl sulfoxide  (ISO)
dimethylarsinic acid  (EXP)
dioscin  (ISO)
dioxygen  (ISO)
dorsomorphin  (ISO)
doxorubicin  (EXP,ISO)
elemental selenium  (ISO)
epoxiconazole  (ISO)
erythromycin estolate  (EXP)
erythrosin B  (ISO)
ethanol  (ISO)
ethyl methanesulfonate  (ISO)
etoposide  (ISO)
fenamidone  (ISO)
fenthion  (ISO)
flutamide  (EXP)
folic acid  (ISO)
fumonisin B1  (ISO)
furosemide  (EXP)
gadolinium trichloride  (ISO)
genistein  (ISO)
gentamycin  (EXP)
glafenine  (EXP)
glutathione  (ISO)
glyphosate  (ISO)
gold atom  (ISO)
gold(0)  (ISO)
hemin  (ISO)
hexachlorobenzene  (EXP)
hydrogen peroxide  (ISO)
hydroquinone  (ISO)
indometacin  (ISO)
irinotecan  (EXP)
isoflurane  (EXP)
isoprenaline  (EXP,ISO)
ketoconazole  (ISO)
L-mimosine  (ISO)
lead nitrate  (ISO)
leflunomide  (ISO)
lenalidomide  (ISO)
lignan  (ISO)
lipopolysaccharide  (EXP,ISO)
luteolin 7-O-beta-D-glucoside  (ISO)
magnesium atom  (EXP)
magnesium oxide  (ISO)
mercury atom  (EXP)
mercury(0)  (EXP)
metformin  (ISO)
methacholine chloride  (ISO)
methidathion  (ISO)
methotrexate  (ISO)
methyl methanesulfonate  (ISO)
methylarsonic acid  (EXP)
methylmercury chloride  (ISO)
methylmercury(1+)  (EXP)
mifepristone  (ISO)
Mitotane  (EXP)
monodansylcadaverine  (ISO)
motexafin gadolinium  (ISO)
mycophenolic acid  (ISO)
mycotoxin  (ISO)
N-acetyl-L-cysteine  (ISO)
N-methyl-4-phenylpyridinium  (ISO)
N-nitrosodiethylamine  (EXP)
N-nitrosodimethylamine  (EXP)
naloxone  (EXP)
nefazodone  (EXP)
neoechinulin A  (ISO)
neohesperidin  (EXP)
nickel atom  (ISO)
nickel dichloride  (EXP)
nickel sulfate  (ISO)
nicotine  (EXP,ISO)
nimesulide  (EXP)
nitrates  (EXP)
Nonidet P-40  (ISO)
notoginsenoside R1  (ISO)
o-anisidine  (ISO)
ochratoxin A  (EXP,ISO)
octreotide  (EXP)
osthole  (ISO)
ozone  (ISO)
paclitaxel  (ISO)
paracetamol  (EXP,ISO)
paraquat  (ISO)
pentobarbital  (EXP)
perfluorononanoic acid  (EXP)
perfluorooctane-1-sulfonic acid  (ISO)
perfluorooctanoic acid  (EXP)
phenobarbital  (EXP)
phorbol 13-acetate 12-myristate  (ISO)
phosphoramide mustard  (EXP)
Phytolaccoside E  (ISO)
prochloraz  (EXP)
progesterone  (EXP,ISO)
propylparaben  (ISO)
prostaglandin E2  (ISO)
pyrethrins  (ISO)
quercetin  (ISO)
quercetin 3-O-beta-D-galactopyranoside  (ISO)
quercetin 3-O-beta-D-glucofuranoside  (EXP)
quercetin 3-O-beta-D-glucopyranoside  (EXP)
quercitrin  (ISO)
quinidine  (EXP)
resiniferatoxin  (ISO)
resveratrol  (ISO)
rose bengal  (ISO)
rotenone  (EXP,ISO)
SB 203580  (ISO)
selenium atom  (ISO)
serpentine asbestos  (ISO)
sesquiterpene  (ISO)
simvastatin  (ISO)
sodium arsenite  (ISO)
sodium stibogluconate  (ISO)
Soman  (EXP)
sterigmatocystin  (ISO)
sulfasalazine  (EXP)
Tanshinone I  (ISO)
tert-butyl hydroperoxide  (ISO)
testosterone  (EXP)
tetrachloromethane  (EXP,ISO)
tetracycline  (EXP)
thalidomide  (ISO)
thioacetamide  (EXP)
thiram  (ISO)
titanium dioxide  (ISO)
TMC-120A  (ISO)
tolcapone  (EXP)
Tomentosin  (ISO)
Tributyltin oxide  (ISO)
trichloroethene  (EXP)
trichostatin A  (EXP,ISO)
trimethyltin  (ISO)
triphenyl phosphate  (ISO)
triptonide  (ISO)
usnic acid  (ISO)
valdecoxib  (EXP)
valproic acid  (ISO)
vancomycin  (ISO)
vinclozolin  (EXP)
vorinostat  (ISO)
VX nerve agent  (ISO)
WR-1065  (ISO)
zerumbone  (ISO)
zinc acetate  (ISO)
zinc atom  (ISO)
zinc molecular entity  (ISO)
zinc protoporphyrin  (ISO)
zinc(0)  (ISO)
zoledronic acid  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
aortic valve development  (ISO)
apoptotic process  (IEA)
cell surface receptor signaling pathway  (ISO,ISS)
cell surface receptor signaling pathway via JAK-STAT  (IEA,ISO)
cellular response to estradiol stimulus  (IEP)
cellular response to mechanical stimulus  (IEA,ISO)
cytokine-mediated signaling pathway  (ISO,ISS)
defense response  (ISO,ISS)
defense response to bacterium  (ISO)
inflammatory response  (IBA,IEA,ISO,ISS)
intrinsic apoptotic signaling pathway in response to DNA damage  (ISO)
negative regulation of apoptotic process  (IMP)
negative regulation of cardiac muscle hypertrophy  (ISO)
negative regulation of extracellular matrix constituent secretion  (ISO)
negative regulation of gene expression  (IDA)
negative regulation of inflammatory response  (IEA,ISO)
negative regulation of interleukin-6 production  (IDA)
positive regulation of angiogenesis  (IMP)
positive regulation of apoptotic process  (IEA)
positive regulation of apoptotic process involved in morphogenesis  (ISO)
positive regulation of canonical NF-kappaB signal transduction  (IEA,ISO)
positive regulation of execution phase of apoptosis  (ISO)
positive regulation of gene expression  (IMP)
positive regulation of inflammatory response  (ISO,ISS)
positive regulation of macromolecule biosynthetic process  (IEA)
positive regulation of neuron apoptotic process  (IMP)
positive regulation of protein import into nucleus  (IMP)
positive regulation of transcription by RNA polymerase II  (IEA,ISO,ISS)
positive regulation of tumor necrosis factor production  (IMP)
prostaglandin metabolic process  (IEA)
protein localization to plasma membrane  (IEA,ISO)
pulmonary valve development  (ISO)
regulation of apoptotic process  (IMP)
regulation of developmental process  (IEA)
regulation of establishment of endothelial barrier  (IEA,ISO)
regulation of gene expression  (IEA)
regulation of multicellular organismal process  (IEA)
regulation of tumor necrosis factor-mediated signaling pathway  (ISO)
response to alkaloid  (IEP)
response to amino acid  (IEP)
response to bacterium  (IEA)
response to ethanol  (IEP)
response to hypoxia  (IEP)
response to lipopolysaccharide  (IEP)
signal transduction  (IEA)
tumor necrosis factor-mediated signaling pathway  (IEA,IMP,ISO)

Cellular Component

Molecular Function

References

References - curated
# Reference Title Reference Citation
1. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Aderka D, etal., Arthritis Rheum. 1993 Aug;36(8):1111-20.
2. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Aderka D, etal., Cancer Res. 1991 Oct 15;51(20):5602-7.
3. Time course profiling of the retinal transcriptome after optic nerve transection and optic nerve crush. Agudo M, etal., Mol Vis. 2008 Jun 3;14:1050-63.
4. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases. Amrani Y, etal., Mol Pharmacol 2001 Oct;60(4):646-55.
5. A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis. Arntz OJ, etal., Arthritis Res Ther. 2010;12(2):R61. doi: 10.1186/ar2974. Epub 2010 Apr 6.
6. Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. Aten J, etal., J Am Soc Nephrol. 2000 Aug;11(8):1426-38.
7. Enhancement of the survival of engrafted mesenchymal stem cells in the ischemic heart by TNFR gene transfection. Bao C, etal., Biochem Cell Biol. 2010 Aug;88(4):629-34.
8. Moxibustion inhibits apoptosis and tumor necrosis factor-alpha/tumor necrosis factor receptor 1 in the colonic epithelium of Crohn's disease model rats. Bao CH, etal., Dig Dis Sci. 2012 Sep;57(9):2286-95. doi: 10.1007/s10620-012-2161-0. Epub 2012 Apr 25.
9. TNFR2 interposes the proliferative and NF-kappaB-mediated inflammatory response by podocytes to TNF-alpha. Bruggeman LA, etal., Lab Invest. 2011 Mar;91(3):413-25. doi: 10.1038/labinvest.2010.199. Epub 2011 Jan 10.
10. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Calfee CS, etal., Crit Care Med. 2011 Jan 28.
11. Expression of tumour necrosis factor receptors by bronchoalveolar cells in hypersensitivity pneumonitis. Chen B, etal., Eur Respir J. 2005 Jun;25(6):1039-43.
12. The effect of intra-articular injection of different concentrations of ozone on the level of TNF-alpha, TNF-R1, and TNF-R2 in rats with rheumatoid arthritis. Chen H, etal., Rheumatol Int. 2013 May;33(5):1223-7. doi: 10.1007/s00296-012-2529-7. Epub 2012 Oct 2.
13. Tumor Necrosis Factor-Alpha Antagonist Reduces Apoptosis of Neurons and Oligodendroglia in Rat Spinal Cord Injury. Chen KB, etal., Spine (Phila Pa 1976). 2011 Jan 8.
14. TNF-alpha enhances the currents of voltage gated sodium channels in uninjured dorsal root ganglion neurons following motor nerve injury. Chen X, etal., Exp Neurol. 2011 Feb;227(2):279-86. Epub 2010 Dec 9.
15. Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients. Cheng X, etal., J Alzheimers Dis. 2010;19(2):621-30. doi: 10.3233/JAD-2010-1253.
16. TNF-alpha is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection. Choi S, etal., Am J Respir Cell Mol Biol. 2011 Feb;44(2):255-60. Epub 2010 May 6.
17. Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. Constantin CE, etal., J Neurosci. 2008 May 7;28(19):5072-81.
18. Contribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose. Costa GN, etal., Mol Cell Neurosci. 2012 May;50(1):113-23. doi: 10.1016/j.mcn.2012.04.003. Epub 2012 Apr 10.
19. Tumor necrosis factor receptor 1 expression is upregulated in dendritic cells in patients with chronic HCV who respond to therapy. Cubillas R, etal., Hepat Res Treat. 2010;2010:429243. doi: 10.1155/2010/429243. Epub 2010 Aug 3.
20. Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease. Culpan D, etal., Exp Gerontol. 2007 Jun;42(6):538-44. doi: 10.1016/j.exger.2006.12.001. Epub 2007 Jan 30.
21. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. Cunningham PN, etal., J Immunol. 2002 Jun 1;168(11):5817-23.
22. The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. Curl L and Sampson W, Aust Orthod J. 2011 Nov;27(2):102-9.
23. Exercise preconditioning reduces brain damage and inhibits TNF-alpha receptor expression after hypoxia/reoxygenation: an in vivo and in vitro study. Ding YH, etal., Curr Neurovasc Res. 2006 Nov;3(4):263-71.
24. Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer. Dobrzycka B, etal., Eur Cytokine Netw. 2009 Sep;20(3):131-4.
25. A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family. Dode C, etal., Arthritis Rheum. 2000 Jul;43(7):1535-42.
26. Sources of alveolar soluble TNF receptors during acute lung injury of different etiologies. Dorr AD, etal., J Appl Physiol. 2011 Apr 21.
27. Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behcet's disease. Duzgun N, etal., Rheumatol Int. 2005 Jan;25(1):1-5. Epub 2003 Nov 5.
28. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eagan TM, etal., Eur Respir J. 2010 Mar;35(3):540-8. Epub 2009 Jul 30.
29. Characterization of DISC formation and TNFR1 translocation to mitochondria in TNF-alpha-treated hepatocytes. Eum HA, etal., Am J Pathol. 2011 Sep;179(3):1221-9. doi: 10.1016/j.ajpath.2011.05.046. Epub 2011 Jul 8.
30. An atherogenic lipid profile with low serum paraoxonase-1 activity during nematode infection in rats. Farid AS, etal., Eur J Clin Invest. 2010 Nov;40(11):984-93. doi: 10.1111/j.1365-2362.2010.02352.x.
31. Astrocyte reactivity to unconjugated bilirubin requires TNF-alpha and IL-1beta receptor signaling pathways. Fernandes A, etal., Glia. 2011 Jan;59(1):14-25. doi: 10.1002/glia.21072. Epub 2010 Oct 21.
32. Structural damage in diabetic nephropathy is associated with TNF-alpha system activity. Fernandez-Real JM, etal., Acta Diabetol. 2012 Aug;49(4):301-5. doi: 10.1007/s00592-011-0349-y. Epub 2011 Nov 1.
33. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Fernandez-Real JM, etal., Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E952-9.
34. Cancer cachexia results in an increase in TNF-alpha receptor gene expression in both skeletal muscle and adipose tissue. Figueras M, etal., Int J Oncol. 2005 Sep;27(3):855-60.
35. TNF receptor 1 and 2 contribute in different ways to resistance to Legionella pneumophila-induced mortality in mice. Fujita M, etal., Cytokine. 2008 Nov;44(2):298-303. Epub 2008 Oct 5.
36. Genetic dissection of a rat model for rheumatoid arthritis: significant gender influences on autosomal modifier loci Furuya T, etal., Hum Mol Genet 2000 Sep 22;9(15):2241-50
37. Polymorphisms of the tumor necrosis factor receptor type 1 locus among autoimmune susceptible and resistant inbred rat strains. Furuya T, etal., Immunogenetics 2001 Jul;53(5):427-9.
38. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer. Gadducci A, etal., Anticancer Res. 1996 Sep-Oct;16(5B):3125-8.
39. Upregulation of TNF-alpha and Receptors Contribute to Endothelial Dysfunction in Zucker Diabetic Rats. Gao X, etal., Am J Biomed Sci. 2010;2(1):1-12.
40. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
41. Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain. Geis C, etal., Neuroscience. 2010 Aug 11;169(1):463-74. doi: 10.1016/j.neuroscience.2010.04.022. Epub 2010 Apr 24.
42. TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness. Gilliam LA, etal., Am J Physiol Lung Cell Mol Physiol. 2011 Feb;300(2):L225-31. Epub 2010 Nov 19.
43. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
44. S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-kappaB pathway in rats. Gong QH, etal., Brain Behav Immun. 2011 Jan;25(1):110-9. Epub 2010 Sep 7.
45. Circulating TNF-alpha and its soluble receptors during experimental acute pancreatitis. Granell S, etal., Cytokine. 2004 Feb 21;25(4):187-91.
46. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Gregory AP, etal., Nature. 2012 Aug 23;488(7412):508-11. doi: 10.1038/nature11307.
47. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Guo G, etal., Am J Physiol. 1999 Nov;277(5 Pt 2):F766-72.
48. Shedding of tumor necrosis factor type 1 receptor after experimental spinal cord injury. Harrington JF, etal., J Neurotrauma. 2005 Aug;22(8):919-28.
49. Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Hasegawa M, etal., Nephron Clin Pract. 2009;113(3):c222-33. doi: 10.1159/000235242. Epub 2009 Aug 18.
50. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. He P, etal., J Cell Biol. 2007 Aug 27;178(5):829-41. doi: 10.1083/jcb.200705042.
51. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein. Himmler A, etal., DNA Cell Biol 1990 Dec;9(10):705-15.
52. Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas. Hosono K, etal., World J Gastroenterol. 2012 Oct 14;18(38):5360-8. doi: 10.3748/wjg.v18.i38.5360.
53. Increased susceptibility to acute kidney injury due to endoplasmic reticulum stress in mice lacking tumor necrosis factor-alpha and its receptor 1. Huang L, etal., Kidney Int. 2011 Mar;79(6):613-23. doi: 10.1038/ki.2010.469. Epub 2010 Dec 8.
54. Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis. Idasiak-Piechocka I, etal., Nephrol Dial Transplant. 2010 Dec;25(12):3948-56. doi: 10.1093/ndt/gfq310. Epub 2010 Jun 4.
55. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Iglesias J, etal., Am J Kidney Dis. 2003 Jan;41(1):62-75.
56. Tumor necrosis factor alpha pathways develops liver apoptosis in type 1 diabetes mellitus. Ingaramo PI, etal., Mol Immunol. 2011 Apr 8.
57. Differences between tumor necrosis factor-alpha receptors types 1 and 2 in the modulation of spinal glial cell activation and mechanical allodynia in a rat sciatic nerve injury model. Ishikawa T, etal., Spine (Phila Pa 1976). 2013 Jan 1;38(1):11-6. doi: 10.1097/BRS.0b013e3182610fa9.
58. Exercise training increases membrane bound form of tumor necrosis factor-alpha receptors with decreases in the secretion of soluble forms of receptors in rat adipocytes. Ito Y, etal., Life Sci 2002 Jun 21;71(5):601-9.
59. Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway. Jacob N, etal., J Immunol. 2009 Feb 15;182(4):2532-41. doi: 10.4049/jimmunol.0802948.
60. Expression of monocyte chemoattractant protein-1 and its induction by tumor necrosis factor receptor 1 in sensory neurons in the ventral rhizotomy model of neuropathic pain. Jeon SM, etal., Neuroscience. 2011 Sep 8;190:354-66. doi: 10.1016/j.neuroscience.2011.06.036. Epub 2011 Jun 25.
61. Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease. Jiang H, etal., Mol Neurodegener. 2011 Oct 6;6:69. doi: 10.1186/1750-1326-6-69.
62. Role of heme oxygenase 1 in TNF/TNF receptor-mediated apoptosis after hepatic ischemia/reperfusion in rats. Kim SJ, etal., Shock. 2013 Apr;39(4):380-8. doi: 10.1097/SHK.0b013e31828aab7f.
63. Interaction of 5-hydroxytryptamine and tumor necrosis factor-alpha to pain-related behavior by nucleus pulposus applied on the nerve root in rats. Kobayashi H, etal., Spine (Phila Pa 1976). 2011 Feb 1;36(3):210-8.
64. Roles of TNF-alpha and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats. Kong SS, etal., Clin Exp Pharmacol Physiol. 2011 Mar 1. doi: 10.1111/j.1440-1681.2011.05505.x.
65. Concomitant apoptosis and regeneration of liver cells as a mechanism of liver-tumor promotion by beta-naphthoflavone involving TNFalpha-signaling due to oxidative cellular stress in rats. Kuwata K, etal., Toxicology. 2011 Apr 28;283(1):8-17. Epub 2011 Feb 2.
66. High-density rat radiation hybrid maps containing over 24,000 SSLPs, genes, and ESTs provide a direct link to the rat genome sequence. Kwitek AE, etal., Genome Res. 2004 Apr;14(4):750-7
67. Soluble tumour necrosis factor receptors as prognostic factors in cancer patients. Langkopf F and Atzpodien J, Lancet. 1994 Jul 2;344(8914):57-8.
68. Polymorphisms in apoptosis-related genes and survival of patients with early-stage non-small-cell lung cancer. Lee EB, etal., Ann Surg Oncol. 2010 Oct;17(10):2608-18. Epub 2010 Apr 27.
69. Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNFalpha) and TNF receptors in rat dorsal root ganglion. Li Y, etal., J Neurosci. 2004 Oct 27;24(43):9623-31.
70. Inhibitory effects of Dendrobium alkaloids on memory impairment induced by lipopolysaccharide in rats. Li Y, etal., Planta Med. 2011 Jan;77(2):117-21. Epub 2010 Aug 17.
71. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition. Lind MH, etal., Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4972-7. Epub 2004 Mar 25.
72. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Liu KD, etal., Crit Care Med. 2007 Dec;35(12):2755-61.
73. Therapeutic hypothermia modulates TNFR1 signaling in the traumatized brain via early transient activation of the JNK pathway and suppression of XIAP cleavage. Lotocki G, etal., Eur J Neurosci. 2006 Oct;24(8):2283-90.
74. Tumor necrosis factor receptor 1 and its signaling intermediates are recruited to lipid rafts in the traumatized brain. Lotocki G, etal., J Neurosci. 2004 Dec 8;24(49):11010-6.
75. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Maury CP, etal., Arthritis Rheum. 2003 Nov;48(11):3068-76.
76. Polymorphism A36G of the tumor necrosis factor receptor 1 gene is associated with PAI-1 levels in obese women. Mavri A, etal., Thromb Haemost. 2007 Jan;97(1):62-6.
77. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
78. Decrease in tumor necrosis factor-alpha receptor-associated death domain results from ubiquitin-dependent degradation in obstructive renal injury in rats. Misaki T, etal., Am J Pathol. 2009 Jul;175(1):74-83. doi: 10.2353/ajpath.2009.080884. Epub 2009 Jun 18.
79. Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass. Molina A, etal., Obes Surg. 2003 Aug;13(4):615-21.
80. TAK1 kinase signaling regulates embryonic angiogenesis by modulating endothelial cell survival and migration. Morioka S, etal., Blood. 2012 Nov 1;120(18):3846-57. doi: 10.1182/blood-2012-03-416198. Epub 2012 Sep 12.
81. CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection. Nagarkar DR, etal., J Immunol. 2009 Nov 15;183(10):6698-707. Epub 2009 Oct 28.
82. Tumor necrosis factor-alpha mediates photoreceptor death in a rodent model of retinal detachment. Nakazawa T, etal., Invest Ophthalmol Vis Sci. 2011 Mar 14;52(3):1384-91. Print 2011 Mar.
83. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
84. Lack of soluble tumor necrosis factor alpha receptor 1 and 2 and interleukin-1beta compartmentalization in lungs of mice after a single intratracheal inoculation with live Porphyromonas gingivalis. Nemec A, etal., Exp Lung Res. 2009 Sep;35(7):605-20.
85. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Niewczas MA, etal., Clin J Am Soc Nephrol. 2009 Jan;4(1):62-70. Epub 2008 Dec 10.
86. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. Niewczas MA, etal., J Am Soc Nephrol. 2012 Mar;23(3):507-15. doi: 10.1681/ASN.2011060627. Epub 2012 Jan 19.
87. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
88. Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis. Ortiz LA, etal., Am J Respir Crit Care Med. 2001 Jan;163(1):244-52.
89. Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat. Parada CA, etal., Eur J Neurosci. 2003 May;17(9):1847-52.
90. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers. Patel K, etal., Int J Cancer. 2010 Sep 7.
91. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
92. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
93. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. Pradillo JM, etal., J Cereb Blood Flow Metab. 2005 Feb;25(2):193-203. doi: 10.1038/sj.jcbfm.9600019.
94. TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning. Pradillo JM, etal., Neuroscience. 2006;138(4):1171-8. Epub 2006 Jan 25.
95. TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis. Raveney BJ, etal., J Immunol. 2009 Aug 15;183(4):2321-9. doi: 10.4049/jimmunol.0901340. Epub 2009 Jul 27.
96. GOA pipeline RGD automated data pipeline
97. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
98. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
99. Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis. Robertson M, etal., Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3034-41.
100. Ethanol increases tumor necrosis factor-alpha receptor-1 (TNF-R1) levels in hepatic, intestinal, and cardiac cells. Rodriguez DA, etal., Alcohol. 2004 May;33(1):9-15.
101. Quantification of the mRNA encoding Tumor Necrosis Factor alpha (TNFalpha) and its receptors in human nasal polyps. Rostkowska-Nadolska B, etal., Adv Med Sci. 2008;53(2):263-9.
102. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy? Rostoker G, etal., Clin Exp Immunol. 1998 Dec;114(3):468-76.
103. 14-Deoxyandrographolide desensitizes hepatocytes to tumour necrosis factor-alpha-induced apoptosis through calcium-dependent tumour necrosis factor receptor superfamily member 1A release via the NO/cGMP pathway. Roy DN, etal., Br J Pharmacol. 2010 Aug;160(7):1823-43.
104. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease. Safranow K, etal., Tissue Antigens. 2009 Nov;74(5):386-92.
105. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. Sainz J, etal., Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):423-36.
106. Differential cellular expression of tumor necrosis factor-alpha and Type I tumor necrosis factor receptor after transient global forebrain ischemia. Sairanen TR, etal., J Neurol Sci. 2001 May 1;186(1-2):87-99.
107. Contribution of TNF-alpha and nuclear factor-kappaB signaling to type 2 iodothyronine deiodinase activation in the mediobasal hypothalamus after lipopolysaccharide administration. Sanchez E, etal., Endocrinology. 2010 Aug;151(8):3827-35. Epub 2010 May 25.
108. Differences in serum cytokine levels between influenza virus A and B infections in children. Sato M, etal., Cytokine. 2009 Jul;47(1):65-8. Epub 2009 Jun 3.
109. Soluble tumor necrosis factor receptor type I enhances tumor development and persistence in vivo. Selinsky CL and Howell MD, Cell Immunol. 2000 Mar 15;200(2):81-7.
110. Soluble tumor necrosis factor alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B. Serwin AB, etal., Photodermatol Photoimmunol Photomed. 2005 Aug;21(4):210-1.
111. Moxibustion treatment restoring the intestinal epithelium barrier in rats with Crohn's disease by down-regulating tumor necrosis factor alpha, tumor necrosis factor receptor 1, and tumor necrosis factor receptor 2. Shi Y, etal., Chin J Integr Med. 2011 Mar;17(3):212-7. Epub 2011 Feb 27.
112. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis. Shimizu T, etal., Clin Rheumatol. 2000;19(5):352-9.
113. Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Shinoda S, etal., Eur J Neurosci. 2003 May;17(10):2065-76.
114. Axonal transport of TNF-alpha in painful neuropathy: distribution of ligand tracer and TNF receptors. Shubayev VI and Myers RR, J Neuroimmunol. 2001 Mar 1;114(1-2):48-56.
115. Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. Sippy BD, etal., J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):511-21.
116. Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina. Sivakumar V, etal., J Pathol. 2011 Jan 17. doi: 10.1002/path.2858.
117. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Sommer C, etal., Exp Neurol. 1998 May;151(1):138-42.
118. The association between BMI and plasma cytokine levels in patients with acute lung injury. Stapleton RD, etal., Chest. 2010 Sep;138(3):568-77. Epub 2010 Apr 30.
119. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia. Sugano M, etal., Circulation. 2004 Feb 17;109(6):797-802.
120. In vivo transfer of soluble TNF-alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats. Sugano M, etal., FASEB J. 2004 May;18(7):911-3. Epub 2004 Mar 19.
121. Role of TNFR1 in lung injury and altered lung function induced by the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide. Sunil VR, etal., Toxicol Appl Pharmacol. 2011 Feb 1;250(3):245-55. Epub 2010 Nov 9.
122. Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis. Swierkot J, etal., Joint Bone Spine. 2015 Mar;82(2):94-9. doi: 10.1016/j.jbspin.2014.08.006. Epub 2014 Oct 11.
123. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. Szretter KJ, etal., J Virol. 2007 Mar;81(6):2736-44. Epub 2006 Dec 20.
124. Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Tezel G, etal., Brain Res. 2004 Jan 23;996(2):202-12.
125. TNFR 2 M196R polymorphism and acne vulgaris in Han Chinese: a case-control study. Tian L, etal., J Huazhong Univ Sci Technolog Med Sci. 2010 Jun;30(3):408-11. doi: 10.1007/s11596-010-0366-z. Epub 2010 Jun 17.
126. Serum cytokine receptor levels in noninfectious uveitis. Torun N, etal., Ophthalmic Res. 2005 Mar-Apr;37(2):112-6. Epub 2005 Mar 3.
127. Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis. Touchard E, etal., Gene Ther. 2009 Jul;16(7):862-73. doi: 10.1038/gt.2009.43. Epub 2009 May 14.
128. Tumor necrosis factor signaling. Wajant H, etal., Cell Death Differ. 2003 Jan;10(1):45-65.
129. Tumor necrosis factor alpha primes cerebral endothelial cells for erythropoietin-induced angiogenesis. Wang L, etal., J Cereb Blood Flow Metab. 2011 Feb;31(2):640-7. Epub 2010 Aug 11.
130. Gene network revealed involvements of Birc2, Birc3 and Tnfrsf1a in anti-apoptosis of injured peripheral nerves. Wang Y, etal., PLoS One. 2012;7(9):e43436. doi: 10.1371/journal.pone.0043436. Epub 2012 Sep 17.
131. Opposing actions of hippocampus TNFalpha receptors on limbic seizure susceptibility. Weinberg MS, etal., Exp Neurol. 2013 Jan 16. pii: S0014-4886(13)00024-1. doi: 10.1016/j.expneurol.2013.01.011.
132. TNFR1-dependent pulmonary apoptosis during ischemic acute kidney injury. White LE, etal., Am J Physiol Lung Cell Mol Physiol. 2012 Sep;303(5):L449-59. doi: 10.1152/ajplung.00301.2011. Epub 2012 Jun 22.
133. [Fas and TNFR1 expressions after cerebral ischemia and reperfusion in rats: association with cell apoptosis and the effects of Bcl-2 overexpression]. Wu G, etal., Nan Fang Yi Ke Da Xue Xue Bao. 2011 Aug;31(8):1298-303.
134. Amelioration of liver injury by continuously targeted intervention against TNFRp55 in rats with acute-on-chronic liver failure. Xu Y, etal., PLoS One. 2013 Jul 16;8(7):e68757. doi: 10.1371/journal.pone.0068757. Print 2013.
135. Expression of the type 1 and type 2 receptors for tumor necrosis factor after traumatic spinal cord injury in adult rats. Yan P, etal., Exp Neurol 2003 Oct;183(2):286-97.
136. Intrathecal ultra-low dose naloxone enhances the antihyperalgesic effects of morphine and attenuates tumor necrosis factor-alpha and tumor necrosis factor-alpha receptor 1 expression in the dorsal horn of rats with partial sciatic nerve transection. Yang CP, etal., Anesth Analg. 2013 Dec;117(6):1493-502. doi: 10.1213/ANE.0000000000000020.
137. Increased expression of tumor necrosis factor receptors in cryptogenic organizing pneumonia. Ye Q, etal., Respir Med. 2011 Feb;105(2):292-7. Epub 2010 Dec 8.
138. Blocking TNF-alpha by combination of TNF-alpha- and TNFR-binding cyclic peptide ameliorates the severity of TNBS-induced colitis in rats. Yin B, etal., Eur J Pharmacol. 2011 Apr 10;656(1-3):119-24. doi: 10.1016/j.ejphar.2011.01.046. Epub 2011 Feb 4.
139. [Effect of intra-articular ozone injection on serum and synovial TNF-alpha, TNFR I, and TNFR II contents in rats with rheumatoid arthritis]. Yu B, etal., Nan Fang Yi Ke Da Xue Xue Bao. 2011 Jun;31(6):1055-8.
140. The roles of TNF-alpha and the soluble TNF receptor I on sleep architecture in OSA. Yue HJ, etal., Sleep Breath. 2009 Aug;13(3):263-9. Epub 2009 Jan 16.
141. Estradiol Increases the Expression of TNF-alpha and TNF Receptor 1 in Lactotropes. Zaldivar V, etal., Neuroendocrinology. 2011;93(2):106-13. Epub 2011 Jan 20.
142. Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Zhang L, etal., Arterioscler Thromb Vasc Biol. 2007 May;27(5):1087-94.
143. Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung. Zhang M, etal., Clin Cancer Res. 2008 Mar 15;14(6):1868-76.
144. Tumor necrosis factor-alpha-induced apoptosis in murine cytomegalovirus retinitis. Zhou J, etal., Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1691-700.
145. Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthma. Zhu L, etal., Int Arch Allergy Immunol. 2010;153(3):223-33. Epub 2010 May 18.
146. Predictive value of conjointly examined IL-1ra, TNF-R I, TNF-R II, and RANTES in patients with primary glomerulonephritis. Zwiech R J Korean Med Sci. 2013 Feb;28(2):261-7. doi: 10.3346/jkms.2013.28.2.261. Epub 2013 Jan 29.
147. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy]. Zwiech R, etal., Pol Arch Med Wewn. 2005 Apr;113(4):326-33.
Additional References at PubMed
PMID:1645445   PMID:7758105   PMID:8387893   PMID:9324362   PMID:9435233   PMID:9551933   PMID:9843922   PMID:11588035   PMID:12477932   PMID:12761501   PMID:12849708   PMID:12851692  
PMID:13130484   PMID:14625205   PMID:14743216   PMID:15033431   PMID:15464762   PMID:16675114   PMID:16705482   PMID:16804967   PMID:17010968   PMID:17049356   PMID:17242187   PMID:17468886  
PMID:17873366   PMID:17917074   PMID:18205044   PMID:18938092   PMID:18990246   PMID:19180511   PMID:19593445   PMID:20092780   PMID:20619468   PMID:21410936   PMID:21692635   PMID:21871121  
PMID:21930713   PMID:21988832   PMID:23134577   PMID:23382219   PMID:23706525   PMID:23756688   PMID:24211183   PMID:24599692   PMID:25738414   PMID:25816133   PMID:26078221   PMID:26491108  
PMID:26504355   PMID:27239114   PMID:27979472   PMID:28710070   PMID:30358805   PMID:32802876   PMID:32979866   PMID:33066952   PMID:34739338   PMID:38897255  


Genomics

Comparative Map Data
Tnfrsf1a
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr84159,837,119 - 159,849,817 (+)NCBIGRCr8GRCr8GRCr8
GRCr8 Ensembl4159,837,032 - 159,849,816 (+)EnsemblGRCr8
mRatBN7.24158,150,815 - 158,163,592 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl4158,150,820 - 158,163,591 (+)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx4164,380,489 - 164,393,199 (+)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.04160,163,415 - 160,176,125 (+)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.04158,802,250 - 158,814,961 (+)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.04157,864,905 - 157,877,634 (+)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl4157,864,969 - 157,877,633 (+)Ensemblrn6Rnor6.0
Rnor_5.04224,881,368 - 224,894,089 (+)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.44162,172,563 - 162,185,252 (+)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera4146,886,949 - 146,899,646 (+)NCBICelera
RGSC_v3.14162,417,498 - 162,430,188 (+)NCBI
RH 3.4 Map41000.9RGD
Cytogenetic Map4q42NCBI
TNFRSF1A
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38126,328,771 - 6,342,076 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl126,328,757 - 6,342,114 (-)Ensemblhg38GRCh38
GRCh37126,437,937 - 6,451,242 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36126,308,184 - 6,321,522 (-)NCBIBuild 36Build 36hg18NCBI36
Build 34126,308,184 - 6,321,522NCBI
Celera128,054,567 - 8,067,927 (-)NCBICelera
Cytogenetic Map12p13.31NCBI
HuRef126,291,179 - 6,304,533 (-)NCBIHuRef
CHM1_1126,437,153 - 6,450,509 (-)NCBICHM1_1
T2T-CHM13v2.0126,338,163 - 6,351,461 (-)NCBIT2T-CHM13v2.0
Tnfrsf1a
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm396125,326,686 - 125,339,446 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl6125,326,325 - 125,339,447 (+)EnsemblGRCm39 EnsemblGRCm39
GRCm386125,349,723 - 125,362,483 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl6125,349,362 - 125,362,484 (+)Ensemblmm10GRCm38
MGSCv376125,299,741 - 125,312,501 (+)NCBIMGSCv37MGSCv37mm9NCBIm37
MGSCv366125,315,374 - 125,328,104 (+)NCBIMGSCv36mm8
Celera6127,020,792 - 127,033,747 (+)NCBICelera
Cytogenetic Map6F3NCBI
cM Map659.32NCBI
Tnfrsf1a
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554133,981,400 - 3,996,021 (-)Ensembl
ChiLan1.0NW_0049554133,982,670 - 3,996,320 (-)NCBIChiLan1.0ChiLan1.0
TNFRSF1A
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v21011,888,472 - 11,902,332 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11211,885,230 - 11,898,580 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0126,457,617 - 6,470,969 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1126,374,256 - 6,387,613 (-)NCBIPanPan1.1PanPan1.1panPan2
PanPan1.1 Ensembl126,374,257 - 6,387,613 (-)EnsemblpanPan2panpan1.1
TNFRSF1A
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.12738,641,837 - 38,654,693 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl2738,638,753 - 38,700,282 (+)EnsemblcanFam3CanFam3.1
Dog10K_Boxer_Tasha277,959,778 - 7,972,628 (-)NCBIDog10K_Boxer_TashaDog10K_Boxer_Tasha
ROS_Cfam_1.02738,997,951 - 39,010,819 (+)NCBIROS_Cfam_1.0ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl2738,997,952 - 39,155,482 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.12738,870,492 - 38,883,352 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.02738,911,954 - 38,924,837 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0277,438,485 - 7,451,382 (-)NCBIUU_Cfam_GSD_1.0UU_Cfam_GSD_1.0
Tnfrsf1a
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_024404945102,735,979 - 102,753,899 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049367091,407,278 - 1,421,921 (+)EnsemblSpeTri2.0 Ensembl
SpeTri2.0NW_0049367091,407,327 - 1,421,448 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
TNFRSF1A
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl564,319,051 - 64,331,909 (+)EnsemblsusScr11Sscrofa11.1
Sscrofa11.1564,319,349 - 64,331,876 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2566,780,726 - 66,793,255 (+)NCBISscrofa10.2Sscrofa10.2susScr3
TNFRSF1A
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.1116,364,544 - 6,378,880 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl116,364,330 - 6,378,902 (-)EnsemblChlSab1.1 EnsemblchlSab2Vervet-AGM
Vero_WHO_p1.0NW_0236660631,856,767 - 1,871,090 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Tnfrsf1a
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_0046248603,111,630 - 3,122,711 (-)EnsemblHetGla_female_1.0 EnsemblhetGla2HetGla_female_1.0 Ensembl
HetGla 1.0NW_0046248603,111,244 - 3,123,041 (-)NCBIHetGla 1.0HetGla 1.0hetGla2
Tnfrsf1a
(Rattus rattus - black rat)
Black Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rrattus_CSIRO_v1622,540,807 - 22,553,712 (-)NCBIRrattus_CSIRO_v1

Variants

.
Variants in Tnfrsf1a
26 total Variants
miRNA Target Status (No longer updated)

Predicted Target Of
Summary Value
Count of predictions:202
Count of miRNA genes:142
Interacting mature miRNAs:152
Transcripts:ENSRNOT00000048529
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCr8)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
6478754Anxrr43Anxiety related response QTL 430.14035locomotor behavior trait (VT:0001392)distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)4146370897184426481Rat
724558Plsm2Polydactyly-luxate syndrome (PLS) morphotypes QTL 20.0003hindlimb integrity trait (VT:0010563)hind foot phalanges count (CMO:0001949)4134095016179095016Rat
1582237Kidm34Kidney mass QTL 3440.0001kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)4149763204169799698Rat
6478693Anxrr32Anxiety related response QTL 320.00092locomotor behavior trait (VT:0001392)measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)4146370897184426481Rat
6478757Anxrr44Anxiety related response QTL 440.01087locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4155834926184426481Rat
1358364Sradr4Stress Responsive Adrenal Weight QTL 44.92adrenal gland mass (VT:0010420)both adrenal glands wet weight (CMO:0000164)4131384565176384565Rat
10755501Bp390Blood pressure QTL 3902.5arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)427730518170099664Rat
61451Ciaa4CIA Autoantibody QTL 43.1blood autoantibody amount (VT:0003725)calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281)4123870974168870974Rat
1331802Srn5Serum renin concentration QTL 53.045renin activity (VT:0005581)plasma renin activity level (CMO:0000116)4117559384162559384Rat
1331738Bp209Blood pressure QTL 2092.979arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)4140059299181024663Rat
6478700Anxrr33Anxiety related response QTL 330.00896locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4146370897184426481Rat
1298524Oia8Oil induced arthritis QTL 8joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4140059299184426481Rat
10053718Scort25Serum corticosterone level QTL 252.150.0097blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)4157292416184426481Rat
738009Sach4Saccharine consumption QTL 44.90.000016consumption behavior trait (VT:0002069)saccharin intake volume to total fluid intake volume ratio (CMO:0001601)460916264184426481Rat
634335Anxrr16Anxiety related response QTL 167.22locomotor behavior trait (VT:0001392)number of entries into a discrete space in an experimental apparatus (CMO:0000960)494638356168870820Rat
737821Hcar9Hepatocarcinoma resistance QTL 93.7liver integrity trait (VT:0010547)volume of individual liver tumorous lesion (CMO:0001078)4106848959168870974Rat
7411558Bw133Body weight QTL 13313.840.001body mass (VT:0001259)body weight gain (CMO:0000420)4127263297172263297Rat
6478778Anxrr51Anxiety related response QTL 510.25384locomotor behavior trait (VT:0001392)measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)4126334185171334185Rat
10401796Kidm48Kidney mass QTL 48kidney mass (VT:0002707)both kidneys wet weight (CMO:0000085)4147299608184426481Rat
6478718Anxrr34Anxiety related response QTL 340.00896locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4146370897184426481Rat
6478782Anxrr52Anxiety related response QTL 520.02091locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4155834926184426481Rat
631511Pia7Pristane induced arthritis QTL 74.3joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4123870974168870974Rat
634347Hcar8Hepatocarcinoma resistance QTL 85.8liver integrity trait (VT:0010547)liver tumorous lesion area to total liver area ratio (CMO:0001075)4124700988169700988Rat
6478720Alc23Alcohol consumption QTL 230.00509drinking behavior trait (VT:0001422)ethanol drink intake rate to body weight ratio (CMO:0001616)4155834926184426481Rat
6478785Anxrr53Anxiety related response QTL 530.01397locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4155834926184426481Rat
738031Alc14Alcohol consumption QTL 147.60.00003consumption behavior trait (VT:0002069)ethanol drink intake rate to body weight ratio (CMO:0001616)460916264174095838Rat
1576316Ept5Estrogen-induced pituitary tumorigenesis QTL 53.8pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)4100752691179366077Rat
1581566Eae21Experimental allergic encephalomyelitis QTL 216.2body mass (VT:0001259)maximum body weight loss to initial body weight ratio (CMO:0001400)4137447185182447185Rat
1578674Bmd12Bone mineral density QTL 123.8femur mineral mass (VT:0010011)compact volumetric bone mineral density (CMO:0001730)4137430611182430611Rat
6478728Anxrr36Anxiety related response QTL 360.01061locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4155834926184426481Rat
738016Alc16Alcohol consumption QTL 163.60.00015consumption behavior trait (VT:0002069)ethanol drink intake rate to body weight ratio (CMO:0001616)460916264184426481Rat
1358202Gluco11Glucose level QTL 112.40.02adipocyte glucose uptake trait (VT:0004185)absolute change in adipocyte glucose uptake (CMO:0000873)486709649168870974Rat
61422Cia13Collagen induced arthritis QTL 134.5joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4134199006168870974Rat
634342Cia24Collagen induced arthritis QTL 244.5joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4148121375176967367Rat
6478733Anxrr37Anxiety related response QTL 370.00095locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4155834926184426481Rat
737978Pia23Pristane induced arthritis QTL 235.3joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4123870974168870974Rat
61362Oia2Oil induced arthritis QTL 20.001joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4140059299184426481Rat
6478737Anxrr38Anxiety related response QTL 380.00159locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4155834926184426481Rat
12798519Anxrr54Anxiety related response QTL 542.540.05locomotor behavior trait (VT:0001392)distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)4116184844161184844Rat
2316958Gluco58Glucose level QTL 5810blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)412212457182430611Rat
6478748Anxrr42Anxiety related response QTL 420.28008locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4146370897184426481Rat
12798525Anxrr57Anxiety related response QTL 573.210.05locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4148834094168870974Rat

Markers in Region
RH94826  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24158,163,236 - 158,163,349 (+)MAPPERmRatBN7.2
Rnor_6.04157,877,279 - 157,877,391NCBIRnor6.0
Rnor_5.04224,893,734 - 224,893,846UniSTSRnor5.0
RGSC_v3.44162,184,898 - 162,185,010UniSTSRGSC3.4
Celera4146,899,292 - 146,899,404UniSTS
RH 3.4 Map41000.9UniSTS
Cytogenetic Map4q42UniSTS
RH142087  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24158,163,215 - 158,163,413 (+)MAPPERmRatBN7.2
Rnor_6.04157,877,258 - 157,877,455NCBIRnor6.0
Rnor_5.04224,893,713 - 224,893,910UniSTSRnor5.0
RGSC_v3.44162,184,877 - 162,185,074UniSTSRGSC3.4
Celera4146,899,271 - 146,899,468UniSTS
Cytogenetic Map4q42UniSTS


Related Rat Strains
The following Strains have been annotated to Tnfrsf1a
ACI/N     BN     DA     F344/NRrrc     LEW    


Expression

RNA-SEQ Expression

alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
renal system
reproductive system
respiratory system
sensory system
visual system
16 12 67 163 91 90 59 92 59 6 356 192 11 142 81 92 31 17 17

Sequence


Ensembl Acc Id: ENSRNOT00000048529   ⟹   ENSRNOP00000042371
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl4159,837,032 - 159,849,816 (+)Ensembl
mRatBN7.2 Ensembl4158,150,820 - 158,163,588 (+)Ensembl
Rnor_6.0 Ensembl4157,864,969 - 157,877,633 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000102042   ⟹   ENSRNOP00000092064
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl4159,837,032 - 159,849,816 (+)Ensembl
mRatBN7.2 Ensembl4158,150,820 - 158,163,588 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000113507   ⟹   ENSRNOP00000080227
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl4159,844,439 - 159,849,816 (+)Ensembl
mRatBN7.2 Ensembl4158,158,214 - 158,163,591 (+)Ensembl
RefSeq Acc Id: NM_013091   ⟹   NP_037223
RefSeq Status: PROVISIONAL
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr84159,837,119 - 159,849,816 (+)NCBI
mRatBN7.24158,150,894 - 158,163,591 (+)NCBI
Rnor_6.04157,864,990 - 157,877,633 (+)NCBI
Rnor_5.04224,881,368 - 224,894,089 (+)NCBI
RGSC_v3.44162,172,563 - 162,185,252 (+)RGD
Celera4146,886,949 - 146,899,646 (+)RGD
Sequence:
RefSeq Acc Id: XM_039107128   ⟹   XP_038963056
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr84159,845,618 - 159,849,817 (+)NCBI
mRatBN7.24158,161,212 - 158,163,592 (+)NCBI
RefSeq Acc Id: NP_037223   ⟸   NM_013091
- Peptide Label: precursor
- UniProtKB: Q91Y93 (UniProtKB/Swiss-Prot),   Q91V30 (UniProtKB/Swiss-Prot),   Q5U1X6 (UniProtKB/Swiss-Prot),   P22934 (UniProtKB/Swiss-Prot),   A0A0G2JSU9 (UniProtKB/TrEMBL),   A6ILU2 (UniProtKB/TrEMBL)
- Sequence:
Ensembl Acc Id: ENSRNOP00000042371   ⟸   ENSRNOT00000048529
RefSeq Acc Id: XP_038963056   ⟸   XM_039107128
- Peptide Label: isoform X1
Ensembl Acc Id: ENSRNOP00000092064   ⟸   ENSRNOT00000102042
Ensembl Acc Id: ENSRNOP00000080227   ⟸   ENSRNOT00000113507
Protein Domains
Death   TNFR-Cys

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P22934-F1-model_v2 AlphaFold P22934 1-461 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Promoters
RGD ID:13693412
Promoter ID:EPDNEW_R3937
Type:initiation region
Name:Tnfrsf1a_1
Description:TNF receptor superfamily member 1A
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.04157,864,947 - 157,865,007EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:621237 AgrOrtholog
BioCyc Gene G2FUF-42992 BioCyc
Ensembl Genes ENSRNOG00000031312 Ensembl, ENTREZGENE
Ensembl Transcript ENSRNOT00000048529 ENTREZGENE
Gene3D-CATH 1.10.533.10 UniProtKB/Swiss-Prot
  Tumor Necrosis Factor Receptor, subunit A, domain 2 UniProtKB/Swiss-Prot
InterPro DEATH-like_dom_sf UniProtKB/Swiss-Prot
  Death_domain UniProtKB/Swiss-Prot
  TNFR/NGFR_Cys_rich_reg UniProtKB/Swiss-Prot
  TNFR_1A UniProtKB/Swiss-Prot
  TNFRSF1A UniProtKB/Swiss-Prot
  TNFRSF1A_death UniProtKB/Swiss-Prot
  TNFRSF1A_N UniProtKB/Swiss-Prot
KEGG Report rno:25625 UniProtKB/Swiss-Prot
NCBI Gene 25625 ENTREZGENE
PANTHER TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1A UniProtKB/Swiss-Prot
  TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1A UniProtKB/Swiss-Prot
Pfam Death UniProtKB/Swiss-Prot
  TNFR_c6 UniProtKB/Swiss-Prot
PharmGKB TNFRSF1A RGD
PhenoGen Tnfrsf1a PhenoGen
PRINTS TNFACTORR1A UniProtKB/Swiss-Prot
PROSITE DEATH_DOMAIN UniProtKB/Swiss-Prot
  TNFR_NGFR_1 UniProtKB/Swiss-Prot
  TNFR_NGFR_2 UniProtKB/Swiss-Prot
RatGTEx ENSRNOG00000031312 RatGTEx
SMART DEATH UniProtKB/Swiss-Prot
  TNFR UniProtKB/Swiss-Prot
Superfamily-SCOP SSF47986 UniProtKB/Swiss-Prot
  TNF receptor-like UniProtKB/Swiss-Prot
UniProt A0A0G2JSU9 ENTREZGENE, UniProtKB/TrEMBL
  A0A8I5ZPP1_RAT UniProtKB/TrEMBL
  A0A8I6GJG3_RAT UniProtKB/TrEMBL
  A6ILU2 ENTREZGENE, UniProtKB/TrEMBL
  P22934 ENTREZGENE
  Q5U1X6 ENTREZGENE
  Q91V30 ENTREZGENE
  Q91Y93 ENTREZGENE
  TNR1A_RAT UniProtKB/Swiss-Prot
UniProt Secondary Q5U1X6 UniProtKB/Swiss-Prot
  Q91V30 UniProtKB/Swiss-Prot
  Q91Y93 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-07-05 Tnfrsf1a  TNF receptor superfamily member 1A  Tnfrsf1a  tumor necrosis factor receptor superfamily, member 1a  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2003-04-09 Tnfrsf1a  tumor necrosis factor receptor superfamily, member 1a      Symbol and Name updated 629477 APPROVED
2003-03-12 Tnfrsf1a  tumor necrosis factor receptor superfamily, member 1a  Tnfr1  Tumor necrosis factor receptor  Data merged from RGD:3878 628472 PROVISIONAL
2002-08-07 Tnfrsf1a        Symbol and Name status set to provisional 70820 PROVISIONAL
2002-06-10 Tnfr1  Tumor necrosis factor receptor      Symbol and Name status set to approved 70586 APPROVED

RGD Curation Notes
Note Type Note Reference
gene_disease nucleotide sequence variants between rat strains may be associated with collagen induced arthritis QTL Cia13 619594
gene_process may contribute to collagen induced arthritis severity QTL Cia13 619594
gene_process human homolog induces MAP kinase activation and may mediate inflammatory response in airway muscle cells 730191